Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 18/20 | 0.44 |
| ▸ | HRH2 | P25021 | 7/20 | 0.40 |
| ▸ | HRH1 | P35367 | 7/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4242399 | 0.81 | AR (0.40) | — | |
| SCHEMBL4233540 | 0.81 | AR (0.41) | — | |
| SCHEMBL4237914 | 0.81 | KDM1A (0.36) | — | |
| SCHEMBL4238953 | 0.81 | USP30 (0.37) | HRH3 | |
| SCHEMBL4231820 | 0.74 | HRH3 (0.46) | HRH3HRH2HRH1SIGMAR1 | |
| SCHEMBL4234289 | 0.74 | MEN1 (0.32) | — | |
| SCHEMBL9366174 | 0.73 | SLC6A2 (0.38) | HRH3 | |
| SCHEMBL4232397 | 0.70 | MYC (0.38) | HRH3HRH1 | |
| SCHEMBL7356174 | 0.69 | HRH3 (0.37) | HRH3 | |
| SCHEMBL4538423 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090233910-A1 | Npy antagonists, preparation and uses | CEREP (FR) | 2009-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090233910-A1 | Npy antagonists, preparation and uses | NPY1R, NPY5R, NPY2R | HRH3 210/4885HRH2 162/4885HRH1 217/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.